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portunities for the genetically complex disease of non-
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Submillisecond pulses of radiation have been shown to
generate less exchange chromosomal aberrations [1, 2]
and a smaller extent of delayed cell death [3, 4] than
continuous irradiation delivered at conventional
dose-rate. This prompted us to determine whether
and how pulsed irradiation affects the response of
normal lung tissue in vivo. For this purpose, C57BL/
6J mice were given a single dose of 17 Gy of 4.5 MeV
electrons in bilateral thorax exposure either at a
high (> 60 Gy/s, beam-on time < 0.5 s, FLASH) or
conventional dose-rate (0.03 Gy/s, beam-on time 8
min, CONV) using an experimental linear electron
accelerator established in the Research Division of
Institut Curie at Orsay (France). DNA damage
response, apoptosis and ﬁbrosis development were
subsequently analyzed at suitable times in the two
modes of irradiation. The anti-tumor efﬁciency was
also evaluated in vivo with two xenografts (HBCx-
12A, HEp-2) and one syngeneic, orthotopic carcinoma
(TC1-Luc). The results indicate that, in the hours
following irradiation, FLASH-irradiated lungs present
less DNA damages and less apoptosis than lungs
irradiated at a conventional dose-rate. Furthermore,
compared to the classical radiation-induced lung
ﬁbrosis observed past 16-weeks after CONV
irradiation, analysis of FLASH-treated lungs did not
show any histological sign of ﬁbrosis nor activation
of the TGF-beta pathway. However, FLASH irradiation
was as efﬁcient as CONV treatment in controlling
tumor growth. Taken together, these results show
that FLASH irradiation selectively spares normal lung
tissue without any loss of the anti-tumor activity [5].
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Malignant cancers are characterized by microenviron-
mental heterogeneity, which is a leading cause of genomic
heterogeneity. Microenvironmental heterogeneity can be
viewed radiographically, wherein non-uniform patterns
of enhancement or attenuation can be associated with
poor outcome. In order to systematically investigate this,
the process of “Radiomics” extracts quantitative ﬁrst,
second and higher order image feature data that can be
statistically mined along with patient data for diagnostic,
predictive and prognostic, models. The radiomics enter-
prise is divided into ﬁve processes with deﬁnable inputs
and outputs: (i) image acquisition and reconstruction; (ii)
image segmentation and rendering; (iii) feature extraction
and qualiﬁcation; (iv) databases and data sharing; and (v)
informatics analyses. Each of these steps poses discrete
challenges that have to be met. Even though this ﬁeld is
still emerging, translationally-directed classiﬁer models
have been generated in detecting and diagnosing a num-
ber of cancer subtypes.
To date, the radiomics effort has focused on computer-
derived “agnostic” (e.g. texture) and radiologist-derived
“semantic” image features, which quantify indescribable
and describable features, respectively. These image
features number in the hundreds and have been
shown to have high prognostic value in both non-small
cell lung cancer, NSCLC, and are being used to classify
indeterminate lung nodules in lung cancer screening CTs.
In NSCLC, prognostic models have been developed for
patients treated with surgery, radiotherapy, or with
targeted therapies. In each of these cases, binary clas-
siﬁers have been used to predict response and/or sur-
vival with accuracies > 80%. In addition, radiomic
features have also been used to predict EGFR and KRAS
mutation status in NSCLC, also with accuracies > 80%.
Current challenges for the nascent ﬁeld of radiomics
include development of a core lexicon of features,
furthering the development and inter-institutional
harmonization of computer-extracted features, and
harmonization of image acquisition parameters for
reduced variance.
